These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 15200737)

  • 1. Concordance evaluation of coronary risk scores: implications for cardiovascular risk screening.
    Reynolds TM; Twomey PJ; Wierzbicki AS
    Curr Med Res Opin; 2004 Jun; 20(6):811-8. PubMed ID: 15200737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study.
    Hippisley-Cox J; Coupland C; Vinogradova Y; Robson J; May M; Brindle P
    BMJ; 2007 Jul; 335(7611):136. PubMed ID: 17615182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "First-hit" heart attack risk calculators on the world wide web: implications for laypersons and healthcare practitioners.
    Roberts EB; Ramnath R; Fallows S; Sykes K
    Int J Med Inform; 2008 Jun; 77(6):405-12. PubMed ID: 17904896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A consultation-based method is equal to SCORE and an extensive laboratory-based method in predicting risk of future cardiovascular disease.
    Petersson U; Ostgren CJ; Brudin L; Nilsson PM
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):536-40. PubMed ID: 19357517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for coronary artery disease in asymptomatic individuals: Why and how?
    Degrell P; Sorbets E; Feldman LJ; Steg PG; Ducrocq G
    Arch Cardiovasc Dis; 2015 Dec; 108(12):675-82. PubMed ID: 26596251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SCORE should be preferred to Framingham to predict cardiovascular death in French population.
    Marchant I; Boissel JP; Kassaï B; Bejan T; Massol J; Vidal C; Amsallem E; Naudin F; Galan P; Czernichow S; Nony P; Gueyffier F
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):609-15. PubMed ID: 20054289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased discordance between HeartScore and coronary artery calcification score after introduction of the new ESC prevention guidelines.
    Diederichsen AC; Mahabadi AA; Gerke O; Lehmann N; Sand NP; Moebus S; Lambrechtsen J; Kälsch H; Jensen JM; Jöckel KH; Mickley H; Erbel R
    Atherosclerosis; 2015 Mar; 239(1):143-9. PubMed ID: 25602856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of different point-of-care testing lipid analysers on cardiovascular disease risk assessment.
    Whitehead SJ; Ford C; Gama R
    J Clin Pathol; 2014 Jun; 67(6):535-9. PubMed ID: 24711512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The accuracy of the Framingham risk-score in different socioeconomic groups: a prospective study.
    Brindle PM; McConnachie A; Upton MN; Hart CL; Davey Smith G; Watt GC
    Br J Gen Pract; 2005 Nov; 55(520):838-45. PubMed ID: 16281999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Danish Cardiovascular Screening Trial (DANCAVAS): study protocol for a randomized controlled trial.
    Diederichsen AC; Rasmussen LM; Søgaard R; Lambrechtsen J; Steffensen FH; Frost L; Egstrup K; Urbonaviciene G; Busk M; Olsen MH; Mickley H; Hallas J; Lindholt JS
    Trials; 2015 Dec; 16():554. PubMed ID: 26637993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for targeted rather than population based screening with C-reactive protein using the National Health and Nutrition Examination Survey (1999 to 2002).
    Guttormsen BN; Stein JH; McBride PE; Cullen MW; Gangnon R; Keevil JG
    Am J Cardiol; 2007 Oct; 100(7):1130-3. PubMed ID: 17884376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and screening of coronary artery disease.
    Anthony D
    Prim Care; 2005 Dec; 32(4):931-46. PubMed ID: 16326220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the Framingham coronary heart disease absolute risk function applicable to Aboriginal people?
    Wang Z; Hoy WE
    Med J Aust; 2005 Jan; 182(2):66-9. PubMed ID: 15651963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing the adverse prognosis of coronary artery calcium.
    Bhatti SK; DiNicolantonio JJ; Captain BK; Lavie CJ; Tomek A; O'Keefe JH
    Mayo Clin Proc; 2013 Aug; 88(8):806-12. PubMed ID: 23910408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The new pooled cohort equations risk calculator.
    Preiss D; Kristensen SL
    Can J Cardiol; 2015 May; 31(5):613-9. PubMed ID: 25843167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The German Coronary Artery Disease Risk Screening Model: development, validation, and application of a decision-analytic model for coronary artery disease prevention with statins.
    Stollenwerk B; Gerber A; Lauterbach KW; Siebert U
    Med Decis Making; 2009; 29(5):619-33. PubMed ID: 19773581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community pharmacist assessment of 10-year risk of coronary heart disease for union workers and their dependents.
    Liu Y; Mentele LJ; McDonough RP; Carruthers KM; Doucette WR
    J Am Pharm Assoc (2003); 2008; 48(4):515-7. PubMed ID: 18653428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying children with special health care needs in the National Health Interview Survey: a new resource for policy analysis.
    Davidoff AJ
    Health Serv Res; 2004 Feb; 39(1):53-71. PubMed ID: 14965077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary artery calcium as a measure of biologic age.
    Shaw LJ; Raggi P; Berman DS; Callister TQ
    Atherosclerosis; 2006 Sep; 188(1):112-9. PubMed ID: 16289071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agreement among cardiovascular disease risk calculators.
    Allan GM; Nouri F; Korownyk C; Kolber MR; Vandermeer B; McCormack J
    Circulation; 2013 May; 127(19):1948-56. PubMed ID: 23575355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.